共 50 条
- [1] SERUM MIRNA PREDICTS VIABLE DISEASE POST-CHEMOTHERAPY IN TESTICULAR NON-SEMINOMA GERM CELL TUMOR PATIENTS JOURNAL OF UROLOGY, 2018, 199 (04): : E494 - E494
- [4] Complications of the post-chemotherapy resection of retroperitoneal residual tumour mass in patients with non-seminomatous testicular germ cell tumours BRITISH JOURNAL OF UROLOGY, 1997, 79 (02): : 263 - 268
- [5] TESTICULAR RADIOMICS CORRELATED WITH PATHOLOGY AT TIME OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMATOUS GERM CELL TUMOR JOURNAL OF UROLOGY, 2023, 209 : E690 - E691
- [7] UTILIZATION AND IMPACT OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION IN ADVANCED NON-SEMINOMATOUS GERM CELL TUMOR JOURNAL OF UROLOGY, 2018, 199 (04): : E491 - E492
- [9] Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor JOURNAL OF UROLOGY, 2018, 200 (01): : 126 - 134